3651 results for «315»
3651 results
A word from our sponsor
15 May 2023 – From PCR Innovators Day 2023
How will "Big Data" and artificial intelligence change the practice in Interventional Cardiology?
15 May 2023 – From PCR Innovators Day 2023
Interventions on Pulmonary Embolism: The Next Big Thing?
15 May 2023 – From PCR Innovators Day 2023
Feedback from Innovator's Exchange Hub
15 May 2023 – From PCR Innovators Day 2023
STEMI Vignettes - The global classroom
18 May 2023 – From EuroPCR 2023
Through these cases, explore global STEMI management and understand various geographic challenges and complication management approaches.
PCR's Got Talent - Round 1 - Session 2
16 May 2023 – From EuroPCR 2023
Did you participate in this session and want to enhance your memory? Take a look at the slides shared by the presenters and revisit the key points worth remembering.
Innovations in Heart Failure: Pumps, Remodeling and Monitoring
15 May 2023 – From PCR Innovators Day 2023
What else will become the "Next Big Thing" in Coronary Artery Disease, Peripheral Vascular, treatment of Hypertension or Cardiovascular Imaging for the Interventional Cardiologist?
15 May 2023 – From PCR Innovators Day 2023
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
